Ok folks, I got the story on NEXM. I just got off the phone with Linda Burns, she is the Sr. Director of Corporate Relations. We are going to see a PR very soon, I'm talking within a couple days announcing the EADV conference taking place in Europe NEXT WEEK!!! At the conference, Novartis will be presenting joint data on NM100060, their Topical Onychomycosis Treatment. This conference begins 9/17/08.
Ms. Burns feels that the recent drop in share price is an overreaction because their Novartis Agreement is still in place and everything is moving forward.
They will receive a 3.5 million dollar payment any time now as soon as their patent that they filed in 2004 is approved!!! The patent office is back logged and Nexmed speaks with them everyday.
The Oct. 15th meeting will be on the subject of Vitaros, their Topical ED Treatment which is moving forward as planned.
That's all for now folks!!! Happy Bargain Shopping!
Market Data 
Markets 
AI
